Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Comparison of the oncological outcomes of stenting as a bridge to surgery and surgery alone in stages II to III obstructive colorectal cancer: a retrospective study

Uehara H, Yamazaki T, Iwaya A, Kameyama H, Komatsu M, Hirai M

Purpose: We evaluated the oncological outcomes of bridge to surgery (BTS) using stent compared with surgery alone for obstructive colorectal cancer. Methods: Consecutive patients who underwent curative resection for stages II...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Slow Nutrient Drinking Test for Evaluating Postprandial Distress Symptom in Japanese Patients With Functional Dyspepsia

Watanabe T, Masaoka T, Kameyama H, Kanai T

  • KMID: 2531216
  • J Neurogastroenterol Motil.
  • 2022 Jul;28(3):424-430.
  • doi: 10.5056/jnm21075
Background/Aims Functional dyspepsia (FD), one of the functional gastrointestinal disorders, is highly prevalent. Impaired gastric accommodation is proposed as a pathophysiology of FD. In order to assess gastric accommodation, a slow...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Small Bowel Obstruction After Ileal Pouch-Anal Anastomosis With a Loop Ileostomy in Patients With Ulcerative Colitis

Kameyama H, Hashimoto , Shimada Y, Yamada S, Yagi R, Tajima Y, Okamura T, Nakano M, Miura K, Nagahashi , Sakata J, Kobayashi , Kosugi SI, Wakai T

PURPOSE: Small bowel obstruction (SBO) remains a common complication after pelvic or abdominal surgery. However, the risk factors for SBO in ulcerative colitis (UC) surgery are not well known. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test

Masaoka T, Kameyama H, Yamane T, Yamamoto Y, Takeuchi H, Suzuki H, Kitagawa Y, Kanai T

  • KMID: 2422848
  • J Neurogastroenterol Motil.
  • 2018 Oct;24(4):577-583.
  • doi: 10.5056/jnm18036
BACKGROUND/AIMS: Potassium-competitive acid blockers are expected to be the next generation of drugs for the treatment of diseases caused by gastric acid. In 2015, vonoprazan fumarate, a novel potassium-competitive acid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr